New Hope for Cystic Fibrosis Patients as EMA Grants Orphan Drug Status to Investigational Treatment ETD001
Enterprise Therapeutics, a biopharmaceutical company based in Brighton, has received a special designation called ‘orphan medicinal product designation’ from the […]
